These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26708913)

  • 1. [Research Advance on Teatment of Second Primary Malignancy in Patients with Multiple Myeloma].
    Ma J; Wang YF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Dec; 23(6):1796-9. PubMed ID: 26708913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the bone marrow microenvironment in multiple myeloma.
    Kawano Y; Moschetta M; Manier S; Glavey S; Görgün GT; Roccaro AM; Anderson KC; Ghobrial IM
    Immunol Rev; 2015 Jan; 263(1):160-72. PubMed ID: 25510276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple myeloma.
    Kumar SK; Rajkumar V; Kyle RA; van Duin M; Sonneveld P; Mateos MV; Gay F; Anderson KC
    Nat Rev Dis Primers; 2017 Jul; 3():17046. PubMed ID: 28726797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Second primary malignancies after the treatment of multiple myeloma].
    Makita S; Maruyama D
    Nihon Rinsho; 2015 Jan; 73(1):162-6. PubMed ID: 25626323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple myeloma.
    Raab MS; Podar K; Breitkreutz I; Richardson PG; Anderson KC
    Lancet; 2009 Jul; 374(9686):324-39. PubMed ID: 19541364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple myeloma.
    Röllig C; Knop S; Bornhäuser M
    Lancet; 2015 May; 385(9983):2197-208. PubMed ID: 25540889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA Barcoding Reveals Habitual Clonal Dominance of Myeloma Plasma Cells in the Bone Marrow Microenvironment.
    Hewett DR; Vandyke K; Lawrence DM; Friend N; Noll JE; Geoghegan JM; Croucher PI; Zannettino ACW
    Neoplasia; 2017 Dec; 19(12):972-981. PubMed ID: 29091798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Shreveport Myeloma Experience: Survival, Risk Factors and Other Malignancies in the Age of Stem Cell Transplantation.
    Munker R; Shi R; Nair B; Devarakonda S; Cotelingam JD; McLarty J; Mills GM; Glass J
    Acta Haematol; 2016; 135(3):146-55. PubMed ID: 26588024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy.
    Chung C
    Pharmacotherapy; 2017 Jan; 37(1):129-143. PubMed ID: 27870103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the Immune Niche within the Bone Marrow Microenvironment: The Rise of Immunotherapy in Multiple Myeloma.
    Podar K; Jager D
    Curr Cancer Drug Targets; 2017; 17(9):782-805. PubMed ID: 28201977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research Progress on Multiple Myeloma with Extramedullary Disease].
    Wang L; Zhang YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):945-8. PubMed ID: 27342539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A patient with prostate cancer and multiple myeloma-diagnostics and possible association of both diseases.
    Sučić M; Bišof V; Cačić M; Kinda SB; Kolenc D; Ljubić N; Sučić T; Potočki K
    Ann Diagn Pathol; 2012 Dec; 16(6):515-20. PubMed ID: 21840230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multiple Myeloma - Current Status in Diagnostic Testing and Therapy].
    Kehrer M; Koob S; Strauss A; Wirtz DC; Schmolders J
    Z Orthop Unfall; 2017 Oct; 155(5):575-586. PubMed ID: 28806822
    [No Abstract]   [Full Text] [Related]  

  • 14. The evolution and impact of therapy in multiple myeloma.
    Laubach JP; Richardson PG; Anderson KC
    Med Oncol; 2010 Jun; 27 Suppl 1():S1-6. PubMed ID: 20169425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
    Lemoli RM; Cavo M; Fortuna A
    J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of interleukin 16 in multiple myeloma.
    Atanackovic D; Hildebrandt Y; Templin J; Cao Y; Keller C; Panse J; Meyer S; Reinhard H; Bartels K; Lajmi N; Sezer O; Zander AR; Marx AH; Uhlig R; Zustin J; Bokemeyer C; Kröger N
    J Natl Cancer Inst; 2012 Jul; 104(13):1005-20. PubMed ID: 22745469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zoledronic acid exerts its antitumor effect in multiple myeloma interfering with the bone marrow microenvironment.
    Corso A; Ferretti E; Lazzarino M
    Hematology; 2005 Jun; 10(3):215-24. PubMed ID: 16019470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell proliferation of myeloma plasma cells: comparison of the blood and marrow compartments.
    Kumar S; Rajkumar SV; Greipp PR; Witzig TE
    Am J Hematol; 2004 Sep; 77(1):7-11. PubMed ID: 15307099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy strategies in multiple myeloma.
    Bae J; Munshi NC; Anderson KC
    Hematol Oncol Clin North Am; 2014 Oct; 28(5):927-43. PubMed ID: 25212890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular pathogenesis of multiple myeloma: chromosomal aberrations, changes in gene expression, cytokine networks, and the bone marrow microenvironment.
    Klein B; Seckinger A; Moehler T; Hose D
    Recent Results Cancer Res; 2011; 183():39-86. PubMed ID: 21509680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.